Kidney Transplant Rejection Market Size
Market Size in USD Bn
CAGR8.8%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 8.8% |
| Market Concentration | Medium |
| Major Players | Eledon Pharmaceuticals, Sangamo Therapeutics, AlloVir, CSL Behring, Hansa Biopharma and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Kidney Transplant Rejection Market Analysis
The kidney transplant rejection market is estimated to be valued at USD 1.63 Bn in 2025 and is expected to reach USD 2.94 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. Factors such as the increasing prevalence of renal diseases, rising geriatric population, and growing awareness about organ transplantation are fueling the demand for effective rejection treatments.